Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STEPAN COSCL · Entity 4733 | VP & GM Surfactants | February 27, 2026 | May 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STEPAN CO
Report date February 27, 2026 · Filed May 12, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,205.2335 |
Reported balance
After 2026-02-27 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-02-27 · Grant · Acquired 56.765 · Balance 14,205.2335 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $50.06 · Expires 2036-03-03 | Direct | 6,440 |
Reported balance
After 2026-03-02 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2026-03-02 · Grant · Acquired 6,440 · Balance 6,440 F1: This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026 (the "Original Filing"). The Original Filing inadvertently reported an incorrect stock appreciation right ("SAR") conversion/exercise price due to an administrative error in the pricing calculation. The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported. This amendment corrects the reported conversion/exercise price. No other aspects of the reported transaction are affected. F2: Vest ratably over three years beginning on the date shown. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 2,247 |
Reported balance
After 2026-03-02 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2026-03-02 · Grant · Acquired 2,247 · Balance 2,247 F3: Each performance share represents a contingent right to receive one share of Stepan Company common stock. F4: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Expires 2029-03-02 | Direct | 4,495 |
Reported balance
After 2026-03-02 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2026-03-02 · Grant · Acquired 4,495 · Balance 4,495 F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F2: Vest ratably over three years beginning on the date shown. |
| Common StockSEC Table I · non-derivative | IndirectBy ESOP II Trust | 4,478.351 |
Reported balance
Holding disclosure · report date 2026-02-27 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance 4,478.351 |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026 (the "Original Filing"). The Original Filing inadvertently reported an incorrect stock appreciation right ("SAR") conversion/exercise price due to an administrative error in the pricing calculation. The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported. This amendment corrects the reported conversion/exercise price. No other aspects of the reported transaction are affected.
F2: Vest ratably over three years beginning on the date shown.
F3: Each performance share represents a contingent right to receive one share of Stepan Company common stock.
F4: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 6, 2026 00:21 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionRestricted Stock Units · Derivative | 571 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000044 · form4.xml · derivative · entry 6 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 572 Underlying: Restricted Stock Units · 571 shares Expires 2027-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F2 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. F4 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 00:21 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 571 | $49.62 | $28,330.17 |
DisclosureSEC source: 0000094049-26-000044 · form4.xml · nonDerivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,876.2335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 00:21 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 166 | $49.62 | $8,236.09 |
DisclosureSEC source: 0000094049-26-000044 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,710.2335 F1 · kind: Withholding of shares to satisfy tax liability on the vesting of RSUs. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:21 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionRestricted Stock Units · Derivative | 1,670 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000044 · form4.xml · derivative · entry 7 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,342 Underlying: Restricted Stock Units · 1,670 shares Expires 2028-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Stepan Company common stock. F2 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. F6 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:21 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,670 | $48.99 | $81,804.95 |
DisclosureSEC source: 0000094049-26-000044 · form4.xml · nonDerivative · entry 4 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,875.2335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:21 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 570 | $48.99 | $27,921.45 |
DisclosureSEC source: 0000094049-26-000044 · form4.xml · nonDerivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,305.2335 F1 · kind: Withholding of shares to satisfy tax liability on the vesting of RSUs. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:41 UTC | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000033 · form4.xml · derivative · entry 5 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,247 Underlying: Common Stock · 2,247 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. F4 · derivative.exercise_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. F4 · derivative.expiration_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:41 UTC | STEPAN CO SCL · Entity 4733 | GrantRestricted Stock Units · Derivative | 4,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000033 · form4.xml · derivative · entry 4 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,495 Underlying: Restricted Stock Units · 4,495 shares Expires 2029-03-02 F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F1 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 00:41 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 7,155 | $0.00 Strike: $17.47 | $0.00 |
DisclosureSEC source: 0000094049-26-000033 · form4.xml · derivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,155 Underlying: Common Stock · 7,155 shares Expires 2036-03-03 F1 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 23:11 UTC Amendment | STEPAN CO SCL · Entity 4733 | GrantRestricted Stock Units · Derivative | 4,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000042 · form4a.xml · derivative · entry 5 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,495 Underlying: Restricted Stock Units · 4,495 shares Expires 2029-03-02 F5 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F1 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 23:11 UTC Amendment | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000042 · form4a.xml · derivative · entry 4 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,247 Underlying: Common Stock · 2,247 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. F4 · derivative.exercise_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. F4 · derivative.expiration_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 23:11 UTC Amendment | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 6,440 | $0.00 Strike: $17.47 | $0.00 |
DisclosureSEC source: 0000094049-26-000042 · form4a.xml · derivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,440 Underlying: Common Stock · 6,440 shares Expires 2036-03-03 F1 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. F2 · derivative.underlying_shares: The Reporting Person's Form 4 filed on March 4, 2026 included an incorrect Stock Appreciation Right amount which has been corrected herein. Read SEC document |
| March 02, 2026 Filed May 12, 2026 23:41 UTC Amendment | STEPAN CO SCL · Entity 4733 | GrantRestricted Stock Units · Derivative | 4,495 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000103 · form4a.xml · derivative · entry 5 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,495 Underlying: Restricted Stock Units · 4,495 shares Expires 2029-03-02 F5 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F2 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| March 02, 2026 Filed May 12, 2026 23:41 UTC Amendment | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 2,247 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000103 · form4a.xml · derivative · entry 4 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,247 Underlying: Common Stock · 2,247 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. F4 · derivative.exercise_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. F4 · derivative.expiration_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. Read SEC document |
| March 02, 2026 Filed May 12, 2026 23:41 UTC Amendment | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 6,440 | $0.00 Strike: $50.06 | $0.00 |
DisclosureSEC source: 0000094049-26-000103 · form4a.xml · derivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,440 Underlying: Common Stock · 6,440 shares Expires 2036-03-03 F1 · derivative.exercise_price: This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026 (the "Original Filing"). The Original Filing inadvertently reported an incorrect stock appreciation right ("SAR") conversion/exercise price due to an administrative error in the pricing calculation. The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported. This amendment corrects the reported conversion/exercise price. No other aspects of the reported transaction are affected. F2 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| February 27, 2026 Filed Mar 5, 2026 00:41 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 56.765 | $52.51 | $2,980.73 |
DisclosureSEC source: 0000094049-26-000033 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,205.2335 Read SEC document |
| February 27, 2026 Filed Mar 5, 2026 23:11 UTC Amendment | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 56.765 | $52.51 | $2,980.73 |
DisclosureSEC source: 0000094049-26-000042 · form4a.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,205.2335 Read SEC document |
| February 27, 2026 Filed May 12, 2026 23:41 UTC Amendment | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 56.765 | $52.51 | $2,980.73 |
DisclosureSEC source: 0000094049-26-000103 · form4a.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,205.2335 Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:00 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionRestricted Stock Units · Derivative | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0000094049-26-000020 · form4.xml · derivative · entry 4 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Restricted Stock Units · 455 shares Expires 2026-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F1 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. F4 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:00 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 158 | $66.39 | $10,489.62 |
DisclosureSEC source: 0000094049-26-000020 · form4.xml · nonDerivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,145.4635 F2 · kind: Withholding of shares to satisfy tax liability on the vesting of RSUs. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 01:00 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 455 | $66.39 | $30,207.45 |
DisclosureSEC source: 0000094049-26-000020 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,303.4635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 19:50 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerPerformance Shares · Derivative | 3,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-010192 · form4.xml · derivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,429 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. F2 · derivative.exercise_date: The performance shares were forfeited due to Stepan Company's performance for the period ending December 31, 2024. F2 · derivative.expiration_date: The performance shares were forfeited due to Stepan Company's performance for the period ending December 31, 2024. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:05 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 568 | $58.19 | $33,051.92 |
DisclosureSEC source: 0001127602-25-009652 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,808.0715 F1 · kind: The transaction reported reflects the withholding of shares from the performance shares vested on February 18, 2025, which were reported on the Form 4 filed for the reporting person on February 19, 2025. Withholding of these shares were applied to the reporting person's account on the transaction date shown. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 15:55 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionRestricted Stock Units · Derivative | 571 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008154 · form4.xml · derivative · entry 8 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,143 Underlying: Restricted Stock Units · 571 shares Expires 2027-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Stepan Company common stock. F1 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. F8 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 15:55 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 168 | $57.28 | $9,622.20 |
DisclosureSEC source: 0001127602-25-008154 · form4.xml · nonDerivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,376.0715 F2 · kind: Withholding of shares to satisfy tax liability on the vesting of RSUs. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 15:55 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 571 | $57.28 | $32,704.03 |
DisclosureSEC source: 0001127602-25-008154 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,544.0715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 15:55 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 7,075 | $0.00 Strike: $59.86 | $0.00 |
DisclosureSEC source: 0001127602-25-008154 · form4.xml · derivative · entry 7 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,075 Underlying: Common Stock · 7,075 shares Expires 2035-03-03 F8 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 15:55 UTC | STEPAN CO SCL · Entity 4733 | GrantRestricted Stock Units · Derivative | 5,012 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008154 · form4.xml · derivative · entry 6 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,012 Underlying: Restricted Stock Units · 5,012 shares Expires 2028-03-03 F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Stepan Company common stock. F8 · derivative.exercise_date: Vest ratably over three years beginning on the date shown. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 15:55 UTC | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 2,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-008154 · form4.xml · derivative · entry 5 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,506 Underlying: Common Stock · 2,506 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. F6 · derivative.exercise_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2027. F6 · derivative.expiration_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2027. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 01:58 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 57.412 | $62.53 | $3,589.97 |
DisclosureSEC source: 0001127602-25-006764 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Indirect · By ESOP II Trust Disclosed balance after: 4,478.351 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 02:39 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionPerformance Shares · Derivative | 2,157 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-005773 · form4.xml · derivative · entry 7 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,157 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ended December 31, 2024. F3 · price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ended December 31, 2024. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ended December 31, 2024. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ended December 31, 2024. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 02:39 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-005773 · form4.xml · nonDerivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,969.9285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ended December 31, 2024. F4 · balance_after: Includes exempt acquisitions under Rule 16a-11 pursuant to dividend reinvestments since the date of the reporting person's last report. F5 · balance_after: Includes exempt acquisitions under Rule 16b-3(c) and Rule 16b-3(d) since the date of the reporting person's last report. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 02:39 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionRestricted Stock Units · Derivative | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-005773 · form4.xml · derivative · entry 6 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455 Underlying: Restricted Stock Units · 455 shares Expires 2026-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F9 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 02:39 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 158 | $62.44 | $9,864.73 |
DisclosureSEC source: 0001127602-25-005773 · form4.xml · nonDerivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,032.9285 F2 · kind: Withholding of shares to satisfy tax liability on the vesting of RSUs. Read SEC document |
| February 14, 2025 Filed Feb 20, 2025 02:39 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 455 | $62.44 | $28,407.93 |
DisclosureSEC source: 0001127602-25-005773 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,190.9285 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:10 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 417 | $87.53 | $36,500.01 |
DisclosureSEC source: 0001127602-24-009532 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,710.4056 F1 · kind: The transaction reported reflects the withholding of shares from the performance shares vested on February 15, 2024. Withholding of these shares was applied to the reporting person's account on the transaction date shown. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:21 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 4,685 | $0.00 Strike: $87.50 | $0.00 |
DisclosureSEC source: 0001127602-24-008891 · form4.xml · derivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,685 Underlying: Common Stock · 4,685 shares Expires 2034-03-04 F4 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:21 UTC | STEPAN CO SCL · Entity 4733 | GrantRestricted Stock Units · Derivative | 1,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-008891 · form4.xml · derivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,714 Underlying: Restricted Stock Units · 1,714 shares Expires 2027-03-04 F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F4 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 23:21 UTC | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 3,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-008891 · form4.xml · derivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,429 Underlying: Common Stock · 3,429 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. F2 · derivative.exercise_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2026. F2 · derivative.expiration_date: The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2026. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 21:36 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 34.689 | $92.04 | $3,192.78 |
DisclosureSEC source: 0001127602-24-007222 · form4.xml · nonDerivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Indirect · By ESOP II Trust Disclosed balance after: 4,337.157 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 20:53 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerPerformance Shares · Derivative | 2,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005655 · form4.xml · derivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,729 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. F3 · derivative.exercise_date: The performance shares were forfeited due to Stepan Company's performance for the period ending December 31, 2023. F3 · derivative.expiration_date: The performance shares were forfeited due to Stepan Company's performance for the period ending December 31, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 20:53 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionPerformance Shares · Derivative | 1,940 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-005655 · form4.xml · derivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,940 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2023. F1 · price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2023. F1 · derivative.exercise_date: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2023. F1 · derivative.expiration_date: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 20:53 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,304 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-005655 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,106.1717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2023. Read SEC document |
| February 15, 2024 Filed Mar 8, 2024 21:00 UTC Amendment | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,323 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-009172 · form4a.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,125.1717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form 4/A corrects the number of shares received as a result of performance shares vesting. The number of shares reported on the reporting person's Form 4 filed on February 20, 2024 was miscalculated due to an administrative error. F2 · price: Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vested upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2023. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:52 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionRestricted Stock Units · Derivative | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-005390 · form4.xml · derivative · entry 4 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 910 Underlying: Restricted Stock Units · 455 shares Expires 2026-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. F6 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:52 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 158 | $89.03 | $14,066.74 |
DisclosureSEC source: 0001127602-24-005390 · form4.xml · nonDerivative · entry 3 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,802.1717 F3 · kind: Withholding of shares to satisfy tax liability on the vesting of RSUs. F1 · balance_after: Includes exempt acquisitions under Rule 16a-11 pursuant to dividend reinvestments since the date of the reporting person's last report. F4 · balance_after: Includes exempt acquisitions under Rule 16b-3(c) and Rule 16b-3(d) since the date of the reporting person's last report. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:52 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 455 | $89.03 | $40,508.65 |
DisclosureSEC source: 0001127602-24-005390 · form4.xml · nonDerivative · entry 2 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,960.1717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The restricted stock units ("RSUs") were settled in shares of common stock per the terms of the award. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 18:59 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 843 | $104.97 | $88,485.50 |
DisclosureSEC source: 0001127602-23-009248 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,480.533 F1 · kind: The transaction reported reflects the withholding of shares from the performance shares vested on February 14, 2023, which were reported on the Form 4 filed for the reporting person on February 16, 2023. Withholding of these shares was applied to the reporting person's account on the transaction date shown. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 22:53 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 90.31 | $109.49 | $9,888.04 |
DisclosureSEC source: 0001127602-23-006278 · form4.xml · nonDerivative · entry 1 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By ESOP II Trust Disclosed balance after: 4,233.527 Read SEC document |
| February 14, 2023 Filed Feb 17, 2023 00:40 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 3,797 | $0.00 Strike: $109.92 | $0.00 |
DisclosureSEC source: 0001127602-23-005697 · form4.xml · derivative · entry 6 Moriarty Sean Thomas · CIK 0001716333 · VP & GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,797 Underlying: Common Stock · 3,797 shares Expires 2033-02-14 F6 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.